CAMP and neoplasm: In contrast, LL-37, ARG1, PGLYRP1 and S100A12 also exhibit antitumor activity affecting tumor cells directly or through the modulation of specific immune and nonimmune stromal cell populations [110,111,112,113,114,115,116].